Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research, has published several articles by winners of the PhRMA Foundation’s 2017 Value Assessment Challenge Awards. The articles, featured in Volume 21, Issue 4 of Value in Health, include three perspectives on “What are transformative strategies to measure or evaluate value of health care interventions that could be implemented to advance a value-driven health care system in the United States?”
A special commentary about value assessment by health policy expert Bryan R. Luce, PhD, of Evidera, Inc., accompanied the articles. Dr. Luce is the Foundation’s review committee chairperson. He reminds us that are there are many windows into the concept of health care value. The top three award winners introduced new concepts to consider vs the traditional term of cost per quality-adjusted life-years saved.
Read about each unique concept:
“A Framework for Measuring Low-Value Care,” by authors from the Altarum Center for Value in Health Care, Arbor, MI.
“Improving Value for Eczema Patients,” by authors from the National Eczema Association.
“Emerging Good Practices for Transforming Value Assessment: Patients’ Voices, Patients’ Values,” by authors from the National Health Council and University of Maryland School of Pharmacy.
The PhRMA Foundation’s Value Assessment Challenge Awards recognize the best and the brightest leaders and institutions that are identifying transformative solutions to measure value in health care and advance a value-driven health care system.
The Challenge Awards are the part of the Foundation’s multi-pronged Value Assessment Initiative, which is aimed at encouraging more evidence-based research on how the true value of medical treatments can be accurately defined and quantified. To date, the Foundation has awarded more than $1.4 million to support a variety of research projects on that topic.
